AJ-3941 ((+/-)-(E)-1-(3-fluoro-6,11-dihydrodibenz[b,e]-oxepine-11-yl ) -4-(3-phenyl-2-propenyl)-
piperazine dimaleate; CAS No. 143110-70-7), a cerebrovascular-selective Ca2+ channel antagonist having anti-
lipid peroxidative action, was reported to prevent
cerebral vasospasm following
subarachnoid hemorrhage in rats. The present study was undertaken to determine whether
AJ-3941 protects the impairment of cerebroarterial endothelium-dependent relaxation which is concomitantly induced with
cerebral vasospasm.
Subarachnoid hemorrhage biphasically suppressed the response to
acetylcholine in rat basilar artery, at 0.5 h (n = 4; P < 0.06) and 1 day (n = 5; P < 0.05) after
subarachnoid hemorrhage. The reduction of the responses was correlated significantly to the degree of vasospasm determined angiographically. This reduction was accompanied by a 49% increase of arterial
lipid peroxide contents. Endothelium-independent relaxation in
subarachnoid hemorrhage rats was preserved in response to 3-morpholinosydnonimine,
sodium nitroprusside and
papaverine.
AJ-3941 prevented (n = 6-8, P < 0.05) the suppression of the
acetylcholine-induced response and the increase in
lipid peroxide content in
subarachnoid hemorrhage rats. These results suggest that
AJ-3941 could exert its vasospasmolytic effect by preserving endothelial function through its anti-
lipid peroxidative action, in addition to its inhibition of vasospasmogen-induced vasoconstriction related to intracellular Ca2+ mobilization.